Utilization analysis of nucleoside antiviral drug in our hospital during 2009-2012
ZHOU Xiao-hua
MENG Xian-min
Abstract：Objective: To analyze the application of nucleoside antiviral drugs in our hospital from 2009 to 2012, discuss the features and changing trend, in order to improve the clinical rational use of nucleoside antiviral drugs. Methods:The DDDs, consumption sum and DDC of nucleoside antiviral drugs were analyzed during the period of 2009-2012. Results:The consumption sum of nucleoside antiviral drugs increased year by year in our hospital. The average consumption of entecavir per year was about 26.013 million Yuan and its constituent ratio was 56%in the consumption of nucleoside antiviral drugs, which was higher than lamivudine, adefovir and telbivudine. The consumption ratio of lamivudine decreased year by year. The DDC of all the drugs decreased slowly. Conclusion:The total consumption of nucleoside antiviral drugs increased year by year in our hospital. Among these drugs, the consumption of entecavir increased significantly, adefovir and telbivudine kept stable, while lamivudine decreased.
Keywords：Nucleoside antiviral drugsDDDDDDsDDC
Publication Date：2013-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 281-282,290 )